The prognostic significance of soluble MIC-A, MIC-B and ULBP2 in CLL has been confirmed in other studies which have shown that among these ligands, soluble ULBP2 is the most important prognostic marker to identify early-stage patients with risk of disease progression [170]. Here, ULBP2 is linked to B-cell chronic lymphocytic leukemia.